Public Market Listing
217730KOSDAQ
Live quotes, historical charts, and market capitalization for Kangstem Biotech are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Furestem-CDNo recent activity | Phase 1/2 | Allogeneic MSC therapyCell therapy | Inflammatory Bowel Disease Crohn's Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
Quarterly & interim (1)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2026-Q3 | — | — | — | — | report ↗ |